Table 1 Patients’ baseline characteristics (n = 121)

Age (years)

62 ± 9

Women, n (%)

50 (41)

Diabetes duration (years)

9 ± 8

Smoking habit, n (%)

30 (25)

Past history of cardiovascular diseases n (%)

17 (14)

Past history of cerebro-cardiovascular diseases n (%)

10 (8)

Family history of cardiovascular diseases, n (%)

74 (61)

Systolic blood pressure (mmHg)

128 ± 11

Diastolic blood pressure (mmHg)

79 ± 8

Hypertension, n (%)

93 (77)

Obesity, n (%)

68 (56)

Dyslipidemia, n (%)

93 (77)

Use of anti-hypertensive therapies

 Beta-blockers, n (%)

18 (15)

 Angiotensin-converting enzyme inhibitors, n (%)

29 (24)

 Calcium entry blockers, n (%)

12 (10)

 Diuretics, n (%)

28 (23)

Use of lipid-lowering drugs

 Statins, n (%)

57 (47)

 Fibrates, n (%)

3 (3)

 Omega-3 fatty acids, n (%)

14 (13)

Aspirin use, n (%)

43 (35)